Our Researchers

Dr. Fasipe's research interests are focused on understanding barriers to transitioning youth with sickle cell to adult care. She desires to improve readiness to transition through active training and mentorship programs. Additionally, she wants to understand the factors related to patients with high care utilization patterns, in particular those with recurrent pain encounters. Dr. Fasipe is working to provide interventions to help improve pain management and hence, decrease the burden of high utilization.

Dr. Tubman is a promising young investigator who has developed successful clinical and research partnerships in the USA and in sub-Saharan Africa. With this unique perspective on sickle cell disease, Dr. Tubman has created an innovative lens through which she pursues sickle cell disease research.

The primary interest of Dr. Bouchier-Hayes' lab is to investigate the molecular mechanisms of apoptosis and how they impact human health and disease. This focus has evolved to include the investigation of non-apoptotic functions of proteins that have long been considered to have roles in apoptosis, the caspase family of proteases. Dr. Bouchier-Hayes' research program is focused on two major areas:

The long term goal of his research is to identify genetic variants that affect the clinical severity of patients with sickle cell anemia (SCA). Sickle cell anemia is a common disorder caused by a single mutation of the beta-globin gene but the individual severity of clinical outcome is highly variable. It is increasingly apparent that some of this variability is due to co-inheritance of genetic variants other than the SCA mutation.

Dr. Tubman is a promising young investigator who has developed successful clinical and research partnerships in the USA and in sub-Saharan Africa. With this unique perspective on sickle cell disease, Dr. Tubman has created an innovative lens through which she pursues sickle cell disease research.